Related Experiment Videos
[Medicinal plants and diabetes mellitus]
V Suchý1, M Zemlicka, E Svajdlenka
1Veterinární a farmaceutická univerzita Brno, Farmaceutická fakulta, Ustav prírodních léciv, Brno. suchyv@vfu.cz
Summary
Diabetes mellitus, a chronic metabolic disorder, affects millions globally. This review explores plant-based treatments for managing hyperglycemia, offering potential new therapeutic avenues.
Area of Science:
- Metabolic disorders
- Vascular and neurological complications
- Global health challenges
Context:
- Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia.
- It affects millions worldwide, leading to severe complications and significant mortality.
- Current treatments are expensive and offer limited relief, necessitating novel therapeutic strategies.
Purpose:
- To review the hypoglycemic and antihyperglycemic properties of plant-derived preparations.
- To highlight the potential of traditional medicinal plants in diabetes management.
- To consolidate existing research on plant-based antidiabetic agents.
Summary:
- This review synthesizes information on the antidiabetic effects of various plant extracts and compounds.
- It focuses on studies investigating the hypoglycemic and antihyperglycemic activities of plant-based treatments.
- Evidence from animal models and limited clinical studies is presented.
Impact:
- Provides a comprehensive overview of plant-based antidiabetic research.
- Supports the exploration of natural products for diabetes treatment and prevention.
- Highlights the need for further clinical validation of herbal remedies for diabetes mellitus.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Acarbose and miglitol are typically...